查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2010008

动物用药品市场：2026-2032年全球市场预测（依动物种类、产品类型、治疗应用、通路和最终用户划分）

Animal Health Market by Animal Type, Product, Therapeutic Application, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，动物用药品市场价值将达到 985 亿美元，到 2026 年将成长至 1,062.2 亿美元，到 2032 年将达到 1,763 亿美元，复合年增长率为 8.67%。

主要市场统计数据
基准年 2025 985亿美元
预计年份：2026年 1062.2亿美元
预测年份 2032 1763亿美元
复合年增长率 (%) 8.67%

简要概述不断发展的动物医疗保健生态系统，重点关注正在重塑临床环境、供应链和相关人员之间合作的驱动因素。

目前动物保健领域正处于公共卫生、食品安全和伴侣动物福利三大关键领域的交汇点。宠物数量的不断增长、畜牧生产系统的日益复杂化以及公众对通用感染疾病风险意识的提高，都推动了对有效的预防和治疗方案的需求。同时，监管监督和管理工作正在重塑产品的研发、核准和推广方式，而这与物种或用途无关。

整个动物保健产业正在经历重大的结构和技术变革，这些变革正在重新定义产品创新、临床实践和分销管道。

目前，该产业正经历一场变革，这场变革正在重新定义临床实务、研究重点和经营模式。数位转型正在加速伴侣动物远端医疗平台和牲畜远距监测工具的普及，使临床医生和生产者能够更快、更准确地做出数据驱动的决策。精准畜牧技术，例如感测器和基因组分析工具，正在透过早期疗育优化生产力和饲料转换率，同时降低疾病发生率。

本研究评估了美国关税政策的变化将如何影响动物健康相关人员。

美国关税政策预计将于2025年进行调整，这可能对动物保健产业产生复杂的影响，远不止于直接的成本压力。关税变化往往会增加进口原材料和成品的成本，从而可能挤压依赖国际供应链的製造商的利润空间。为了因应这种情况，企业通常会调整筹资策略，转向本地供应商或扩大国内产能，以降低贸易政策变化所带来的风险。

透过全面的细分框架所得出的见解，明确了动物种类、产品形式、治疗用途、分销管道和最终用户行为。

一套精细的细分框架揭示了临床需求、商业性机会和营运复杂性在整个动物用药品组合中的交汇点。依动物种类划分，市场涵盖伴侣动物和家畜。伴侣动物市场主要集中在猫和狗，预防医学、诊断和慢性病管理占据主导地位。而家畜市场则包括水产养殖、牛、家禽和猪，每种动物在生物安全、疫苗接种和饲料管理方面都有其独特的优先事项，这反映了它们各自的生产系统和疾病风险状况。

影响全球动物保健市场产品引进、供应链设计和商业化策略的区域趋势和法规环境。

区域趋势对整个动物保健市场的监管、供应链和产品采纳率都有显着影响。美洲地区呈现出多元化的特征：完善的法律规范、成熟的伴侣动物照护市场以及需要严格生物安全措施的大规模商业畜牧业。在该地区，私人兽医诊所和一体化生产系统正在推动对诊断、疫苗和饲料优化解决方案的需求，而数位化管道正日益成为传统分销网络的有力补充。

为了保持竞争优势，产业领导者正在采取以创新、供应链韧性和打入市场策略。

该领域的主要企业正采取策略方针，强调加强研发、多元化产品组合和创新管道。他们正将资源投入新型疫苗平台和分子诊断技术，同时拓展饲料添加剂和生技药品领域的能力，以应对合理使用抗菌药物（AMS）的挑战。製药开发商与技术供应商之间的策略合作正在加速基于诊断的治疗路径与数位医疗服务的整合。

为动物用药品产业的企业主管提供切实可行的、有影响力的行动方案，以增强韧性、加速数位化并推动临床和商业性成果。

动物保健产业的领导者应采取果断切实可行的措施，在瞬息万变的环境中掌握机会、规避风险。首先，他们应优先考虑灵活的生产结构和供应商多元化，以减轻政策波动和物流波动的影响。这包括确保关键原材料的替代来源，投资建设区域生技药品填充和包装能力，以及协商能够根据原材料成本波动调整价格的合约条款。

采用透明、多方面的研究途径，结合一手访谈、第二手资料整合和严格的检验，以支持策略洞察。

本研究融合了定性和定量方法，以得出严谨且切实可行的分析结果。初步研究包括对兽医、生产经理、采购负责人和行业专家进行结构化访谈，以了解他们对临床需求、采购因素和分销挑战的第一手观点。作为补充，第二阶段研究利用监管文件、科学文献、专利申请和公开的企业资讯披露，揭示了技术进步和竞争对手的市场定位。

对产业趋势的简明扼要、综合分析突显了创新、监管和业务永续营运之间的相互作用如何推动未来的动物健康策略。

总之，在技术创新、法规演变和经营模式变革的驱动下，动物保健产业正经历根本性的重组。诊断技术和疫苗平台的进步、数位医疗和精准农业的兴起，以及对合理使用抗菌药物日益重视，正在重塑产品开发和服务交付模式。同时，供应链韧性和区域策略对于保障基本治疗和预防产品的可近性至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：动物用药品市场：依动物类型划分

  • 伴侣动物
    • 猫
    • 狗
  • 家畜
    • 水产养殖
    • 牛
    • 家禽
    • 猪

第九章：动物用药品市场：依产品分类

  • 诊断药物
    • 免疫学诊断
    • 分子诊断
  • 饲料添加剂
    • 酵素
    • 益生元
    • 益生菌
  • 杀虫剂
    • 体外寄生虫控製剂
    • 体内寄生虫控製剂
  • 製药
    • 品牌商品
    • 学名药
  • 疫苗
    • 灭活疫苗
    • 活病毒疫苗
    • 重组

第十章：依治疗应用分類的动物用药品市场

  • 抗感染药物
    • 抗生素
    • 抗真菌药物
    • 抗病毒药物
  • 抗发炎药
    • 皮质类固醇
    • NSAIDs
  • 驱虫
    • 体外寄生虫控製剂
    • 体内寄生虫控製剂
  • 荷尔蒙製剂
    • 生长激素
    • 生殖荷尔蒙

第十一章：动物用药品市场：依通路划分

  • 网路商店
    • 消费者网站
    • 第三方平台
  • 离线
    • 连锁药局
    • 独立经营药房

第十二章：动物用药品市场：依最终用户划分

  • 动物饲主
    • 畜牧业的棋子
    • 宠物饲主
  • 饲料生产商
  • 兽医
    • 大型动物兽医
    • 全科兽医
    • 小动物兽医

第十三章：动物用药品市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章动物用药品市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章动物用药品市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国动物用药品市场

第十七章：中国动物用药品市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Alltech, Inc.
  • Boehringer Ingelheim International GmbH
  • Cargill, Incorporated
  • Ceva Sante Animale SA
  • Chr. Hansen Holding A/S
  • Covetrus, Inc.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • HIPRA, SA
  • Huvepharma AD
  • IDEXX Laboratories, Inc.
  • Kemin Industries, Inc.
  • Koninklijke DSM NV
  • Merck & Co., Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-434CCDA04CF9

The Animal Health Market was valued at USD 98.50 billion in 2025 and is projected to grow to USD 106.22 billion in 2026, with a CAGR of 8.67%, reaching USD 176.30 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 98.50 billion
Estimated Year [2026] USD 106.22 billion
Forecast Year [2032] USD 176.30 billion
CAGR (%) 8.67%

A concise orientation to the evolving animal health ecosystem highlighting drivers that reshape clinical practice, supply chains, and stakeholder collaborations

The contemporary animal health landscape occupies a critical nexus between public health, food security, and companion animal welfare. Rising pet ownership, intensifying livestock production systems, and heightened public awareness of zoonotic risks have elevated demand for robust preventive and therapeutic solutions. At the same time, regulatory scrutiny and stewardship initiatives are reshaping how products are developed, approved, and deployed across species and use cases.

Integration of human and animal health priorities has prompted closer collaboration among veterinarians, producers, and public health authorities, strengthening the One Health framework. Technological advances in diagnostics, biologics, and data analytics are enabling earlier detection of disease, more precise interventions, and improved monitoring of treatment outcomes. Meanwhile, consumer-driven preferences for sustainability, transparency, and reduced antimicrobial use are influencing product development pathways and commercial strategies.

Transitioning from traditional models, the sector now emphasizes resilience: diversified supply chains, digital-enabled service delivery, and cross-disciplinary R&D partnerships. These trends require stakeholders to reassess capabilities across research, manufacturing, distribution, and field services. As emerging technologies and policy shifts converge, leaders must balance immediate clinical needs with long-term strategic positioning to safeguard animal health and related human health objectives.

Major structural and technological shifts are redefining product innovation, clinical practice, and distribution channels across the animal health industry

The industry is in the midst of transformative shifts that are redefining clinical practice, research priorities, and commercial models. Digital transformation is accelerating adoption of telemedicine platforms for companion animals and remote monitoring tools for livestock, enabling clinicians and producers to make data-driven decisions with greater speed and precision. Precision livestock farming technologies, including sensors and genomic tools, are reducing disease incidence through earlier intervention while optimizing productivity and feed efficiency.

In product innovation, biologics and recombinant vaccine platforms are gaining traction alongside next-generation diagnostics that bring molecular testing closer to point-of-care settings. There is also a clear pivot toward feed additives that support gut health and immunity, reflecting a broader move to reduce reliance on traditional antibiotics. Concurrently, regulatory and antimicrobial stewardship programs are increasing demand for alternative therapies and tightened labeling and usage protocols.

Commercially, consolidation among suppliers and strategic partnerships between pharmaceutical developers and technology providers are reshaping competitive dynamics. Evolving distribution channels, notably online sales and direct-to-consumer models, are changing how owners and veterinarians access products. As a result, organizations that integrate technological capability, regulatory foresight, and customer-centric distribution will capture differentiated value across species and markets.

Assessing how shifts in United States tariff policy could reshape supply chains, procurement decisions, and pricing dynamics for animal health stakeholders

Anticipated adjustments to United States tariff policy in 2025 present a complex set of implications for the animal health sector that extend beyond immediate cost pressures. Tariff changes tend to increase the landed cost of imported raw materials and finished products, which can compress margins for manufacturers reliant on international supply chains. In response, firms often reassess sourcing strategies, shifting toward nearer-shore suppliers or expanding domestic manufacturing capacity to mitigate exposure to trade policy volatility.

These adjustments also influence the logistics and timing of critical inputs such as vaccine components, diagnostic reagents, and specialized feed additives. Heightened customs clearance times and documentation requirements can create temporary bottlenecks that affect cold-chain continuity for biologics and time-sensitive deliveries for clinical diagnostics. As a consequence, distribution partners and veterinary clinics may adopt more conservative inventory practices, which can increase working capital needs and require more sophisticated demand forecasting capabilities.

Trade policy shifts frequently catalyze market realignment, with some countries diverting export flows away from tariff-affected routes and others capitalizing on competitive advantages to fill supply gaps. For companies, proactive measures include redesigning procurement contracts to include tariff pass-through clauses, investing in tariff classification expertise, and pursuing strategic inventory buffers at regional hubs. Importantly, pricing strategies must balance cost recovery with customer willingness to pay, and transparent communication with end users is essential to maintain trust during periods of cost adjustment. Over the medium term, firms that combine supply chain diversification, flexible manufacturing, and commercial agility will be best positioned to absorb policy-driven shocks while continuing to serve veterinarians, producers, and pet owners effectively.

Insights derived from a comprehensive segmentation framework that clarifies species, product modalities, therapeutic uses, distribution channels, and end-user behaviors

A nuanced segmentation framework reveals where clinical need, commercial opportunity, and operational complexity intersect across animal health portfolios. When viewed by animal type, the market spans companion animals and livestock; the companion animal segment concentrates on cats and dogs where preventive care, diagnostics, and chronic disease management dominate, while the livestock segment includes aquaculture, cattle, poultry, and swine, each with specific biosecurity, vaccination, and feed management priorities that reflect production systems and disease risk profiles.

Product-focused segmentation distinguishes diagnostics, feed additives, parasiticides, pharmaceuticals, and vaccines. Diagnostics bifurcate into immunological and molecular methods, enabling point-of-care screening and deeper genomic insights respectively. Feed additives encompass enzymes, prebiotics, and probiotics aimed at optimizing digestion and resilience, whereas parasiticides include ectoparasiticides and endoparasiticides tailored to species-specific parasite burdens. Pharmaceuticals split into branded and generic offerings, while vaccines cover killed inactivated, live attenuated, and recombinant formats with divergent manufacturing and regulatory pathways.

Therapeutic application segmentation clarifies clinical positioning across anti-infectives, anti-inflammatories, antiparasitics, and hormonal therapeutics. Anti-infectives further differentiate into antibiotics, antifungals, and antivirals, with stewardship pressures influencing use profiles. Anti-inflammatories are divided into corticosteroids and NSAIDs, reflecting efficacy and safety trade-offs. Antiparasitics include both ecto- and endoparasiticides, and hormonal therapeutics encompass growth and reproductive hormones used primarily in production settings.

Distribution channel segmentation exposes the shifting routes to market that affect reach and service models. Online stores, split between direct-to-consumer websites and third-party platforms, are expanding access and convenience; retail pharmacies, including chain and independent outlets, remain important for pet owners; and veterinary hospitals and clinics, ranging from large animal hospitals to small animal clinics, continue to be pivotal for prescribing and administering treatments. End-user segmentation identifies animal owners, feed manufacturers, and veterinarians as primary decision-makers, with animal owners comprising livestock farmers and pet owners, and veterinarians categorized into large animal, mixed practice, and small animal practitioners, each influencing product selection and adoption pathways.

Regional dynamics and regulatory environments that shape product adoption, supply chain design, and commercialization strategies across global animal health markets

Regional dynamics exert a strong influence on regulation, supply chains, and adoption rates across animal health markets. The Americas region presents a diverse profile: established regulatory frameworks, mature companion animal care markets, and large-scale commercial livestock operations with intensive biosecurity needs. In this geography, private veterinary practice and integrated production systems drive demand for diagnostics, vaccines, and feed optimization solutions, while digital channels increasingly supplement traditional distribution networks.

Europe, Middle East & Africa exhibits a multifaceted landscape shaped by stringent regulatory standards in many European markets, rising adoption of stewardship frameworks, and heterogeneity across Middle Eastern and African production systems. Demand in this region tends to prioritize high-quality vaccines and diagnostics, antimicrobial stewardship, and tailored support for smallholder and commercial producers. Infrastructure variability across countries underscores the need for adaptable distribution and cold-chain strategies.

The Asia-Pacific region is characterized by rapid modernization of production systems, significant aquaculture activity, and evolving companion animal care markets. Growing investment in local manufacturing and R&D coexists with reliance on cross-border trade for specialized inputs. Regulatory reform, increasing regulatory capacity, and strong private sector participation are accelerating uptake of advanced biologics and molecular diagnostics. Across regions, companies must tailor commercial approaches to regulatory environments, channel structures, and the varying priorities of veterinarians, producers, and pet owners.

Strategic playbooks adopted by industry leaders focusing on innovation, supply chain resilience, and go-to-market modernization to maintain competitive advantage

Leading companies in the sector are adopting strategic postures that emphasize R&D intensity, portfolio diversification, and channel innovation. Firms are allocating resources toward novel vaccine platforms and molecular diagnostics while expanding capabilities in feed additives and biologics that address antimicrobial stewardship concerns. Strategic alliances between pharmaceutical developers and technology vendors enable faster integration of diagnostic-guided treatment pathways and digital health services.

Commercially, organizations are optimizing distribution through a mix of direct-to-clinic relationships and digital sales channels. Investments in cold-chain logistics and regional manufacturing capacities reduce exposure to supply disruptions and trade policy shifts. In parallel, some companies are pursuing selective M&A to acquire complementary technologies, strengthen presence in high-growth species segments, or secure access to regional markets.

Operational excellence remains a priority: advanced quality systems, regulatory affairs expertise, and scalable contract manufacturing relationships support faster product launches and lifecycle management. Companies that balance innovation with pragmatic supply chain and commercialization strategies will sustain competitiveness. Moreover, sustained engagement with veterinarians and producers-through training, technical support, and performance data-sharing-reinforces product value propositions and drives adoption.

Practical high-impact actions for company executives to strengthen resilience, accelerate digital adoption, and drive clinical and commercial outcomes in animal health

Leaders in animal health should take decisive, actionable steps to capture opportunity and mitigate risk across a dynamic landscape. First, prioritize flexible manufacturing and supplier diversification to reduce exposure to policy-driven disruptions and logistics volatility. This includes validating alternative sources for critical inputs, investing in regional fill-finish capacity for biologics, and negotiating contracts that allow pricing adjustments aligned with input cost fluctuations.

Second, accelerate digital transformation initiatives that connect diagnostics to care pathways and enable telemedicine and remote monitoring for both companion animals and livestock. Integrating diagnostic data with treatment protocols enhances clinical outcomes and supports value-based conversations with payers and producers. Third, invest in antimicrobial stewardship and alternative therapeutics, pairing these efforts with educational programs for veterinarians and producers to drive responsible use and meet regulatory expectations.

Fourth, tailor commercial models by region and end user, combining direct engagement with veterinarians, digital DTC experiences for pet owners, and strategic partnerships with feed manufacturers. Finally, embed sustainability and transparency into product lifecycles-ranging from raw material sourcing to packaging choices-to address customer and regulatory demands and to differentiate brands over the long term. Implementing these actions in a coordinated manner will strengthen resilience, accelerate adoption, and create measurable value across portfolios.

A transparent, multi-method research approach combining primary interviews, secondary evidence synthesis, and rigorous triangulation to underpin strategic findings

This research synthesizes qualitative and quantitative approaches to produce a rigorous, actionable analysis. Primary research included structured interviews with veterinarians, production managers, procurement professionals, and industry experts to capture frontline perspectives on clinical needs, purchasing drivers, and distribution challenges. Complementing this, secondary research drew on regulatory publications, scientific literature, patent filings, and publicly available company disclosures to map technological trajectories and competitive positioning.

Data triangulation techniques validated insights across sources, ensuring consistency between field feedback and documented trends. Segmentation analyses employed species, product modality, therapeutic application, distribution channel, and end-user lenses to surface differentiated opportunities and constraints. Regional assessments combined policy reviews with logistics and infrastructure analyses to determine how geography shapes adoption and supply chain design.

Analytical rigor was maintained through iterative hypothesis testing, peer review, and scenario analysis to stress-test assumptions related to trade policy impacts and technology adoption. Limitations include variability in regulatory timelines across jurisdictions and heterogeneous data quality in certain regional contexts; these were addressed by transparency in assumptions and by prioritizing primary stakeholder input where secondary data were sparse. Ethical considerations upheld confidentiality and voluntary participation for all interview subjects.

A concise synthesis of sector dynamics that highlights the interplay of innovation, regulation, and operational resilience driving future animal health strategies

In conclusion, the animal health sector is experiencing a fundamental reconfiguration driven by technological innovation, regulatory evolution, and shifting commercial models. Advances in diagnostics and vaccine platforms, the rise of digital health and precision livestock farming, and growing emphasis on antimicrobial stewardship collectively reshape product development and service delivery. Simultaneously, supply chain resilience and regional strategy have become central to sustaining access to essential therapeutics and preventive products.

Industry participants that align R&D priorities with stewardship goals, invest in flexible manufacturing and regional distribution, and deploy customer-centric digital offerings will be better positioned to capture long-term value. Equally important is proactive engagement with regulatory authorities and veterinary communities to ensure that new modalities achieve clinical acceptance and regulatory compliance. By synthesizing practical operational measures with strategic investment in innovation, organizations can navigate near-term policy disruptions while building durable competitive advantage.

Looking forward, continued collaboration across the public and private sectors, coupled with evidence-driven commercialization and responsible use practices, will be essential to advancing animal health outcomes, protecting public health, and supporting sustainable food systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Health Market, by Animal Type

  • 8.1. Companion Animals
    • 8.1.1. Cats
    • 8.1.2. Dogs
  • 8.2. Livestock
    • 8.2.1. Aquaculture
    • 8.2.2. Cattle
    • 8.2.3. Poultry
    • 8.2.4. Swine

9. Animal Health Market, by Product

  • 9.1. Diagnostics
    • 9.1.1. Immunological Diagnostics
    • 9.1.2. Molecular Diagnostics
  • 9.2. Feed Additives
    • 9.2.1. Enzymes
    • 9.2.2. Prebiotics
    • 9.2.3. Probiotics
  • 9.3. Parasiticides
    • 9.3.1. Ectoparasiticides
    • 9.3.2. Endoparasiticides
  • 9.4. Pharmaceuticals
    • 9.4.1. Branded
    • 9.4.2. Generics
  • 9.5. Vaccines
    • 9.5.1. Killed Inactivated
    • 9.5.2. Live Attenuated
    • 9.5.3. Recombinant

10. Animal Health Market, by Therapeutic Application

  • 10.1. Anti Infectives
    • 10.1.1. Antibiotics
    • 10.1.2. Antifungals
    • 10.1.3. Antivirals
  • 10.2. Anti Inflammatories
    • 10.2.1. Corticosteroids
    • 10.2.2. NSAIDs
  • 10.3. Antiparasitics
    • 10.3.1. Ectoparasiticides
    • 10.3.2. Endoparasiticides
  • 10.4. Hormonal Therapeutics
    • 10.4.1. Growth Hormones
    • 10.4.2. Reproductive Hormones

11. Animal Health Market, by Distribution Channel

  • 11.1. Online Stores
    • 11.1.1. Direct To Consumer Websites
    • 11.1.2. Third Party Platforms
  • 11.2. Offline
    • 11.2.1. Chain Pharmacies
    • 11.2.2. Independent Pharmacies

12. Animal Health Market, by End User

  • 12.1. Animal Owners
    • 12.1.1. Livestock Farmers
    • 12.1.2. Pet Owners
  • 12.2. Feed Manufacturers
  • 12.3. Veterinarians
    • 12.3.1. Large Animal Veterinarians
    • 12.3.2. Mixed Practice Veterinarians
    • 12.3.3. Small Animal Veterinarians

13. Animal Health Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal Health Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Health Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Animal Health Market

17. China Animal Health Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alltech, Inc.
  • 18.6. Boehringer Ingelheim International GmbH
  • 18.7. Cargill, Incorporated
  • 18.8. Ceva Sante Animale SA
  • 18.9. Chr. Hansen Holding A/S
  • 18.10. Covetrus, Inc.
  • 18.11. Dechra Pharmaceuticals PLC
  • 18.12. Elanco Animal Health Incorporated
  • 18.13. Heska Corporation
  • 18.14. HIPRA, S.A.
  • 18.15. Huvepharma AD
  • 18.16. IDEXX Laboratories, Inc.
  • 18.17. Kemin Industries, Inc.
  • 18.18. Koninklijke DSM N.V.
  • 18.19. Merck & Co., Inc.
  • 18.20. Neogen Corporation
  • 18.21. Phibro Animal Health Corporation
  • 18.22. Vetoquinol S.A.
  • 18.23. Virbac S.A.
  • 18.24. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL HEALTH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANIMAL HEALTH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ANIMAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ANIMAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL HEALTH MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL HEALTH MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL HEALTH MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PET OWNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PET OWNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL VETERINARIANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL VETERINARIANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL VETERINARIANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MIXED PRACTICE VETERINARIANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MIXED PRACTICE VETERINARIANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MIXED PRACTICE VETERINARIANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL VETERINARIANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL VETERINARIANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL VETERINARIANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS ANIMAL HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPE ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPE ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPE ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 288. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 290. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 292. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 294. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 296. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 298. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 302. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 304. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 305. AFRICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 306. AFRICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. AFRICA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 308. AFRICA ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 309. AFRICA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 310. AFRICA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 311. AFRICA ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 312. AFRICA ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 313. AFRICA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 314. AFRICA ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 315. AFRICA ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. AFRICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 317. AFRICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 318. AFRICA ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 319. AFRICA ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 320. AFRICA ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 321. AFRICA ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 322. AFRICA ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 323. AFRICA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 324. AFRICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 325. AFRICA ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 335. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 336. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 337. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 338. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 339. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 340. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 341. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 342. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 343. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 344. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MI